HUP0102549A3 - Platinum complex, its preparation and therapeutic application - Google Patents

Platinum complex, its preparation and therapeutic application

Info

Publication number
HUP0102549A3
HUP0102549A3 HU0102549A HUP0102549A HUP0102549A3 HU P0102549 A3 HUP0102549 A3 HU P0102549A3 HU 0102549 A HU0102549 A HU 0102549A HU P0102549 A HUP0102549 A HU P0102549A HU P0102549 A3 HUP0102549 A3 HU P0102549A3
Authority
HU
Hungary
Prior art keywords
preparation
platinum complex
therapeutic application
therapeutic
application
Prior art date
Application number
HU0102549A
Other languages
English (en)
Original Assignee
Pliva Lachema As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Lachema As filed Critical Pliva Lachema As
Publication of HUP0102549A2 publication Critical patent/HUP0102549A2/hu
Publication of HUP0102549A3 publication Critical patent/HUP0102549A3/hu
Publication of HU224716B1 publication Critical patent/HU224716B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0102549A 1998-05-27 1999-05-24 Platinum complex, its preparation and therapeutic application HU224716B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19981628A CZ288912B6 (cs) 1998-05-27 1998-05-27 Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující
PCT/CZ1999/000015 WO1999061451A1 (en) 1998-05-27 1999-05-24 Platinum complex, its preparation and therapeutic application

Publications (3)

Publication Number Publication Date
HUP0102549A2 HUP0102549A2 (hu) 2001-11-28
HUP0102549A3 true HUP0102549A3 (en) 2004-04-28
HU224716B1 HU224716B1 (en) 2006-01-30

Family

ID=5463562

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102549A HU224716B1 (en) 1998-05-27 1999-05-24 Platinum complex, its preparation and therapeutic application

Country Status (24)

Country Link
US (1) US6503943B1 (hu)
EP (1) EP1082330B1 (hu)
JP (1) JP3575686B2 (hu)
CN (1) CN1124279C (hu)
AU (1) AU741380B2 (hu)
BG (1) BG64599B1 (hu)
BR (1) BR9910669B1 (hu)
CA (1) CA2332054C (hu)
CZ (1) CZ288912B6 (hu)
DE (1) DE69901177T2 (hu)
ES (1) ES2175968T3 (hu)
HR (1) HRP20000791B1 (hu)
HU (1) HU224716B1 (hu)
IL (1) IL139529A (hu)
MX (1) MXPA00011621A (hu)
NO (1) NO328930B1 (hu)
PL (1) PL191132B1 (hu)
PT (1) PT1082330E (hu)
RS (1) RS49738B (hu)
RU (1) RU2200164C2 (hu)
SI (1) SI1082330T1 (hu)
SK (1) SK284436B6 (hu)
UA (1) UA56315C2 (hu)
WO (1) WO1999061451A1 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295584B6 (cs) * 2004-02-12 2005-08-17 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice
BRPI0408805A (pt) * 2003-03-31 2006-03-28 Pliva Lachema As composição farmacêutica contendo complexo de platina e método de fabricação da mesma
CZ296045B6 (cs) * 2003-03-31 2005-12-14 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby
EP2298291A3 (en) 2004-06-18 2011-08-03 Agennix USA Inc. Kinase inhibitors for treating cancers
AU2005275205A1 (en) * 2004-07-14 2006-02-23 Gpc Biotech Ag Variable-dose packaging system
CZ2004945A3 (cs) * 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ296459B6 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
WO2007008247A2 (en) * 2004-11-10 2007-01-18 University Of South Florida Platinum complexes for targeted drug delivery
EP1859797A4 (en) * 2005-02-28 2011-04-13 Eisai R&D Man Co Ltd NEW SIMULTANEOUS USE OF A SULPHONAMIDE COMPOUND AND A MEDIUM AGAINST CANCER
EP1792622A1 (en) 2005-11-11 2007-06-06 GPC Biotech AG Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300120B6 (cs) * 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
KR100829173B1 (ko) * 2006-09-19 2008-05-13 광주과학기술원 물에 대한 용해도가 우수한 플라틴 복합체의 포접복합체 및그 제조방법
GB2457452B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Amorphous form of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) amminedichloroplatinum (IV)
GB2457454B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Polymorphic crystalline form II of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) ammine dichloroplatinum (IV)
GB2457455B (en) * 2008-02-12 2010-04-21 Pliva Lachema As Polymorphic crystalline form (I) of (OC-6-43)-Bis(Acetato)-1-(Tricyclo[3,3,1,1 (3,7)]Decylamine)Amminedichloroplatinum(IV)
GB2457453B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Polymorphic crystalline form III of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) ammine dichloroplatinum (IV)
WO2010149666A1 (en) 2009-06-22 2010-12-29 Medexis S.A. Methods for treating neoplasia
WO2011029639A2 (en) 2009-09-08 2011-03-17 Medexis S.A. Compounds and methods for treating neoplasia
WO2012013816A1 (en) 2010-07-30 2012-02-02 Medexis S.A. Compounds and methods for treating neoplasia
PL3189064T3 (pl) 2014-09-03 2019-01-31 Vuab Pharma A.S. Kompleks platyny (IV) o zwiększonej skuteczności przeciwnowotworowej
CN104984356A (zh) * 2015-05-14 2015-10-21 昆明贵研药业有限公司 赛特铂的环糊精复合物及制备方法
RU2613513C2 (ru) * 2015-07-17 2017-03-16 Федеральное государственное бюджетное учреждение науки Институт проблем химической физики Российской академии наук (ИПХФ РАН) Способ получения комплексов платины (IV) с аминонитроксильными радикалами
RU2726826C2 (ru) * 2016-12-27 2020-07-15 Общество с ограниченной ответственностью "Плат-АН" (ООО "Плат-АН") Композиция на основе аминонитроксильного комплекса платины и доксорубицина и способ лечения опухолей
WO2021043402A1 (en) * 2019-09-05 2021-03-11 Vuab Pharma A.S. New platinum iv complexes with substantially increased antitumor efficacy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2063119T3 (es) * 1988-02-02 1995-01-01 Johnson Matthey Inc Complejos de pt (iv).
FI905018A0 (fi) * 1989-10-17 1990-10-12 Bristol Myers Squibb Co I vatten och loesningsmedel loesliga axiala hydroxi-och mono- och dikarboxylsyraderivat med stor tumoeraktivitet.
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
JPH10265380A (ja) * 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤

Also Published As

Publication number Publication date
CA2332054C (en) 2005-06-28
PL344346A1 (en) 2001-11-05
ES2175968T3 (es) 2002-11-16
CN1124279C (zh) 2003-10-15
NO20005990L (no) 2000-11-27
CZ288912B6 (cs) 2001-09-12
SK17732000A3 (sk) 2001-05-10
YU71900A (sh) 2002-10-18
HRP20000791A2 (en) 2001-02-28
UA56315C2 (uk) 2003-05-15
RS49738B (sr) 2008-04-04
JP2002516332A (ja) 2002-06-04
AU741380B2 (en) 2001-11-29
HU224716B1 (en) 2006-01-30
WO1999061451A1 (en) 1999-12-02
SI1082330T1 (en) 2002-08-31
BR9910669A (pt) 2001-01-30
PL191132B1 (pl) 2006-03-31
NO20005990D0 (no) 2000-11-27
DE69901177D1 (de) 2002-05-08
HRP20000791B1 (en) 2006-07-31
HUP0102549A2 (hu) 2001-11-28
SK284436B6 (sk) 2005-04-01
JP3575686B2 (ja) 2004-10-13
EP1082330B1 (en) 2002-04-03
BG64599B1 (bg) 2005-08-31
IL139529A0 (en) 2001-11-25
RU2200164C2 (ru) 2003-03-10
US6503943B1 (en) 2003-01-07
IL139529A (en) 2004-06-20
NO328930B1 (no) 2010-06-21
DE69901177T2 (de) 2002-10-02
CN1303388A (zh) 2001-07-11
AU3809399A (en) 1999-12-13
CA2332054A1 (en) 1999-12-02
EP1082330A1 (en) 2001-03-14
CZ162898A3 (cs) 1999-12-15
PT1082330E (pt) 2002-09-30
MXPA00011621A (es) 2003-03-12
BR9910669B1 (pt) 2011-07-26
BG104972A (en) 2001-08-31

Similar Documents

Publication Publication Date Title
HUP0102549A3 (en) Platinum complex, its preparation and therapeutic application
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
IL139286A0 (en) Polyol-ifn-beta conjugates, their preparation and use
EP0710667A3 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
HK1019605A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
HK1048999A1 (zh) 氮雜䓬吲衍生物，它們的製備和應用
PL343512A1 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
PL351250A1 (en) Antipicornaviral compounds, their preparation and use
EP1053315A4 (en) GENE OF CALVITIS IN MEN, PROTEIN AND USES THEREOF
HK1031725A1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
HUP0201762A2 (en) Platinum complex, its preparation and therapeutic application
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
IL148446A0 (en) Iren protein, its preparation and use
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
GB2332671B (en) Acetals, their preparation and their use
AU3153199A (en) Azacycloalkane derivatives, preparation and therapeutic application
AU3715499A (en) Citronellyl and/or dihydrocitronellyl lactates, preparation and use thereof
HUP0203678A3 (en) Nitro-sulfobenzamide-derivatives, preparation and use thereof
HUP0203455A3 (en) 2-arylquinoline derivatives, preparation and therautic use thereof
AU5522499A (en) 2-aminoethyl-quinoline derivatives, preparation and therapeutic use
HUP0100584A3 (en) Triazepinones, process for their preparation and their therapeutic application
HU9800542D0 (en) Epoxy-azetidinones, preparation and use thereof
IL134604A0 (en) Nap protein, its preparation and use
ZA991021B (en) Benzofuran-4-carboxamides and their therapeutic use.

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20051205

MM4A Lapse of definitive patent protection due to non-payment of fees